TRUSELTIQ is indicated for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma harboring an FGFR2 fusion or rearrangement as detected by an FDA-approved test. This indication received accelerated approval based on overall response rate and duration of response.
ONGENTYS® is indicated as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing "off" episodes.
EMFLAZA is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
Neovascular (Wet) Age-Related Macular Degeneration (nAMD).
Diabetic Macular Edema (DME).
Macular Edema Following Retinal Vein Occlusion (RVO).
DATROWAY is indicated for adult patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer (IHC 0, IHC 1+, or IHC 2+/ISH-) who have received prior endocrine-based therapy and chemotherapy in the metastatic or unresectable setting.
- Indications for Datopotamab Deruxtecan (Datroway) Datopotamab Deruxtecan (Datroway) is a novel Trop-2-directed antibody-drug conjugate (ADC) linked to a topoisomerase inhibitor. It has demonstrated favorable efficacy in the treatment of specific types of breast cancer.
Oct 28, 2025, 10:04 GMT+08:00
- How to Use Datopotamab deruxtecan (Datroway) Datopotamab deruxtecan (Datroway) is a Trop-2-targeted antibody-drug conjugate (ADC) indicated for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Oct 20, 2025, 11:46 GMT+08:00
TRUSELTIQ is indicated for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma harboring an FGFR2 fusion or rearrangement as detected by an FDA-approved test. This indication received accelerated approval based on overall response rate and duration of response.
ONGENTYS® is indicated as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing "off" episodes.
EMFLAZA is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
Neovascular (Wet) Age-Related Macular Degeneration (nAMD).
Diabetic Macular Edema (DME).
Macular Edema Following Retinal Vein Occlusion (RVO).
DATROWAY is indicated for adult patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer (IHC 0, IHC 1+, or IHC 2+/ISH-) who have received prior endocrine-based therapy and chemotherapy in the metastatic or unresectable setting.
VAFSEO is indicated specifically for the treatment of anemia due to chronic kidney disease in adult patients receiving dialysis for a minimum of three months.
- How to Purchase Nelarabine (Atriance) Nelarabine (Atriance) is an intravenous medication used to treat relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). Due to its specific indications and potential severe neurotoxicity (such as coma, seizures, etc.), its purchase and use must strictly follow medical guidance.
502
2025-10-28 13:19:27 - What Are the Side Effects of Nilotinib? Nilotinib is a tyrosine kinase inhibitor used for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML), primarily indicated for adult patients in the chronic phase and accelerated phase who are resistant or intolerant to imatinib. 501
2025-10-28 13:16:15
- Precautions for Nilotinib Administration Nilotinib is a second-generation inhibitor targeting Bcr-Abl tyrosine kinase, primarily indicated for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+CML) who are resistant or intolerant to imatinib. 501
2025-10-28 13:14:12
- How to Use Nilotinib Nilotinib is an inhibitor that targets the Bcr-Abl kinase, primarily indicated for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML) who are resistant or intolerant to imatinib. 502
2025-10-28 13:11:59
- How to Purchase Nilotinib Nilotinib (trade name: Tasigna®) is a targeted drug used for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+CML). Due to its specific indications and potential severe side effects, its purchase and use must strictly follow medical guidance. 502
2025-10-28 13:09:50
- What Are the Side Effects of Dimethyl Fumarate (Tecfidera)? Dimethyl Fumarate (Tecfidera) is an oral medication used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. 502
2025-10-28 13:07:25
- Precautions for Dimethyl Fumarate (Tecfidera) Administration Dimethyl Fumarate (Tecfidera) is an oral medication used to treat relapsing forms of multiple sclerosis (MS). It is indicated for adult patients with clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. 502
2025-10-28 13:05:02
- Indications for Dimethyl Fumarate (Tecfidera) Dimethyl Fumarate (Tecfidera) is an oral medication approved by the U.S. FDA for the treatment of relapsing forms of multiple sclerosis (MS). As a delayed-release capsule, it regulates the immune response through a unique pharmacological mechanism. 502
2025-10-28 13:03:13
- How to Purchase Dimethyl Fumarate (Tecfidera) Dimethyl Fumarate (Tecfidera) is a prescription medication used to treat relapsing forms of multiple sclerosis (MS), with its main active ingredient being dimethyl fumarate. As a specialized therapeutic drug, its purchase and use must strictly comply with medical regulations and precautions. 502
2025-10-28 11:59:24
- What Are the Side Effects of Voranigo? Voranigo is a targeted therapeutic drug for IDH1/2-mutant low-grade gliomas (grade 2 astrocytomas or oligodendrogliomas). As a new type of isocitrate dehydrogenase inhibitor, its efficacy has been verified in clinical trials, but patients need to fully understand its potential side effects and medication precautions. 501
2025-10-28 11:52:43
